4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-034459
Director acquired 4,507 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GOWEN MAXINE Director | 2023-06-02 | Option exercise | +4,507 | 12,301 | D | ||
| Derivatives | |||||||
| GOWEN MAXINE Director | 2023-06-01 | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | D | ||
| GOWEN MAXINE Director | 2023-06-01 | Grant or award · Restricted Stock Units | +4,660 | 4,660 | D | ||
| GOWEN MAXINE Director | 2023-06-02 | Option exercise · Restricted Stock Units | −4,507 | 0 | D | ||
Loading xslF345X04/doc4.xml…